Ledger.Open graph →
SEC Form D · filed August 16, 2022

Skylark Bio, Inc

Offering
$34.9M
Sold
$22.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Steve A. Gillis · Cambridge, MADirectorGiampiero A. De Luca · Cambridge, MADirectorDaniel Portillo · San Francisco, CADirectorPhineas Barnes · San Francisco, CADirectorNilay Thakar · Cambridge, MAExec · DirectorKip Mcclanahan · Austin, TXDirectorIgnace O. Van Waesberghe · New York, NYDirectorNilay Thakar · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗